Nexam Chemical Holding AB (publ)

DB:NC4 Stock Report

Market Cap: €27.3m

Nexam Chemical Holding Past Earnings Performance

Past criteria checks 0/6

Nexam Chemical Holding's earnings have been declining at an average annual rate of -8.4%, while the Chemicals industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 8% per year.

Key information

-8.4%

Earnings growth rate

-3.7%

EPS growth rate

Chemicals Industry Growth12.4%
Revenue growth rate8.0%
Return on equity-4.8%
Net Margin-4.4%
Next Earnings Update30 Jan 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Nexam Chemical Holding makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:NC4 Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24201-9830
30 Jun 24203-10840
31 Mar 24191-21880
31 Dec 23190-23880
30 Sep 23195-24900
30 Jun 23206-23920
31 Mar 23220-15880
31 Dec 22222-13870
30 Sep 22223-10840
30 Jun 22217-9800
31 Mar 22221-7800
31 Dec 21219-5790
30 Sep 21209-7780
30 Jun 21200-6760
31 Mar 21177-8680
31 Dec 20166-8650
30 Sep 20151-11630
30 Jun 20141-14600
31 Mar 20140-13600
31 Dec 19130-17590
30 Sep 19128-15560
30 Jun 19122-17570
31 Mar 19115-17550
31 Dec 18110-17530
30 Sep 1890-4510
30 Jun 1866-2410
31 Mar 1843-5360
31 Dec 1719-6290
30 Sep 1711-21240
30 Jun 1710-22250
31 Mar 1710-22250
31 Dec 168-22240
30 Sep 169-19190
30 Jun 1612-16270
31 Mar 168-16240
31 Dec 158-22240
30 Sep 156-29440
30 Jun 152-34340
31 Mar 152-38340
31 Dec 142-35320
30 Sep 140-33280
30 Jun 141-31280
31 Mar 142-28270
31 Dec 133-27270

Quality Earnings: NC4 is currently unprofitable.

Growing Profit Margin: NC4 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: NC4 is unprofitable, and losses have increased over the past 5 years at a rate of 8.4% per year.

Accelerating Growth: Unable to compare NC4's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: NC4 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (7.2%).


Return on Equity

High ROE: NC4 has a negative Return on Equity (-4.8%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 15:00
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nexam Chemical Holding AB (publ) is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hanna ForsgrenABG Sundal Collier Sponsored
null nullABG Sundal Collier Sponsored
Mattias HolmbergDNB Markets